Lanean...
Annual biologic treatment cost for new and existing patients with moderate to severe plaque psoriasis in Greece
AIM: The aim of the present study was to estimate the annual per-patient cost of treatment with adalimumab, etanercept, infliximab, and ustekinumab by response status for new and existing patients with moderate to severe psoriasis in Greece. METHODS: An economic analysis was developed from a nationa...
Gorde:
| Argitaratua izan da: | Clinicoecon Outcomes Res |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dove Medical Press
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4293299/ https://ncbi.nlm.nih.gov/pubmed/25609988 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S75263 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|